Abstract. The ineffective immune response in patients with the acquired immune deficiency syndrome (AIDS) contributes to severe and widespread infections and unrestricted growth by certain tumors. To determine whether monocyte dysfunction contributes to this immunosuppressed condition, we investigated monocyte chemotaxis in patients with AIDS. Using three different chemotactic stimuli, N-formylmethionylleucylphenylalanine, lymphocyte-derived chemotactic factor, and C5a des Arg, we studied the chemotactic responses of monocytes from seven homosexual men with AIDS, three homosexuals with lymphadenopathy and an abnormal immunological profile, seven healthy homosexual men, and 23 heterosexual control individuals. Monocytes from each of the AIDS patients with Kaposi's sarcoma and/or opportunistic infection exhibited a marked reduction in chemotaxis to all stimuli compared with the healthy control subjects. The reduced chemotactic responses were observed over a wide range of concentrations for each stimulus. Monocytes from AIDS patients who had clinically apparent opportunistic infection(s) exhibited a greater reduction in monocyte migration to all three stimuli than monocytes from the AIDS patient with only Kaposi's sarcoma. Monocytes from each of three homosexuals with lymphadenopathy and an abnormal immunological profile exhibited decreased chemotactic responses that were intermediate between those of the AIDS patients and the healthy heterosexual control subjects. In contrast to these findings, monocytes from each of seven healthy homosexuals exhibited nor-
Introduction
The acquired immune deficiency syndrome (AIDS)' is a new disease that is characterized clinically by a high incidence of certain neoplasms particularly Kaposi's sarcoma (KS) and/or opportunistic infections (01) and immunologically by profound immunosuppression (1) (2) (3) (4) (5) . The disease has a predilection for male homosexuals, intravenous drug abusers, certain Haitians, and residents of certain developing countries (1) (2) (3) (4) (5) (6) . Thus far there have been no reports of spontaneous or therapeutically induced remission in this disease. The immunosuppression was thought initially to be confined to lymphoid cell dysfunction as evidenced by depressed in vivo and in vitro T lymphocyte function and by a depletion of the helper/inducer T cell subset leading to a reversal of the T helper to T suppressor ratio (7) . In addition, cytotoxic T cell and natural killer (NK) cell activity are reduced in patients with AIDS (8) . Recently, B lymphocytes from AIDS patients were shown to exhibit marked polyclonal activation as manifested by spontaneous Ig production and defective proliferation responses to T cell-independent B cell mitogens (7) . The immunosuppression in AIDS thus appears to involve both T and B lymphocyte and NK cell function.
In the setting of this profound immunosuppression, infection with a wide variety of organisms occurs in patients with AIDS. These organisms include the viruses, cytomegalovirus, Epstein-Barr virus, and Herpes simplex; the bacteria, Mycobacterium avium intracellulare; the fungi, Candida albicans and Cryptococcus neoformans; and the protozoans, Pneumocystis carinii, cryptosporidia, Toxoplasma gondii, Isospora belli, Entamoeba histolytica, and Giardia lamblia (1) (2) (3) (4) (5) (6) 9) . Although infections with all of these organisms may occur secondary to an underlying primary immunosuppression, certain of them such as cytomegalovirus can induce immunosuppression (10, 11) .
The monocyte-macrophage, which has received little attention in AIDS, is involved in the host response to many of the above organisms and participates in many T and B lymphocyte activities (12) (13) (14) (15) (16) . Therefore, we have initiated a series of investigations into monocyte-macrophage function in patients with AIDS. In the current report, we investigated monocyte chemotactic responses to a variety of defined chemoattractants in vitro. We report that monocytes from AIDS patients exhibit a marked defect in chemotactic function. This defect may contribute to the depressed immune response to many of the organisms prevalent in AIDS patients. Thus, the immune defect in AIDS, previously thought to involve only the T and B lymphocyte, extends to the monocyte-macrophage.
Methods
Subjects. Ten homosexual males were studied: seven fulfilled the Centers for Disease Control's criteria of AIDS (17) and three had lymphadenopathy with an abnormal immunological profile. The following three groups of age and sex-matched control subjects also were studied: group 1, 23 healthy heterosexual males; group 2, seven healthy homosexual males without evidence of lymphadenopathy or AIDS; and group 3, 12 patients with diseases and/or therapy to control in part for conditions and/or therapy often associated with AIDS. These patients included three with bacterial sepsis on broad spectrum antibiotic coverage, three with Hodgkins' disease on chemotherapy, one with diffuse histiocytic lymphoma on chemotherapy, and five who were anergic as determined by negative skin test reactivity. The anergic patients included three with active tuberculosis on antituberculous drugs, one with sarcoidosis, and one with Wegener's granulomatosis on immunosuppressive therapy. The pertinent clinical and laboratory features of the homosexual patients, the healthy control subjects, and the control patients are presented in Table I .
Mononuclear cell suspensions. Mononuclear leukocytes (MNL) Chemotaxis assay. Patient and control mononuclear leukocytes were suspended in Gey's balanced salt solution (BSS; National Institutes of Health Media Unit) containing 2% bovine serum albumin, 100 U/ ml penicillin, 100 Atg/ml streptomycin, and 0.15 M Hepes and adjusted to a monocyte density of 1 X 106/ml. The chemotactic stimuli diluted in Gey's BSS with veronal buffer (VB) were placed in the bottom wells of microchamber plates (Neuroprobe, Rockville, MD) that were separated from the upper wells by a polycarbonate filter with 5.0 Am pores (Neuroprobe) (28) . Each chamber contained Gey's BSS with VB as a negative control that, along with the stimuli, was tested in triplicate. Following incubation for 90 min in a humidified atmosphere containing 5% C02, the filters were removed, fixed, and stained with Diff-Quik (American Scientific Products, Columbia, MD). The cells that had migrated through the filters were then enumerated with an Optomax Image Analyzer (Optomax Inc., Hollis, NH) using a neutral density filter system that readily distinguishes cells from filter pores. Chemotactic activity is defined as the mean (±SEM) number of monocytes that migrated through the filter pores in three standard fields determined at low magnification (X 16) by the Image Analyzer, which encompasses most of the field for each of triplicate filters. Standard error of the mean of these nine determinations for each point was routinely <10% of the mean. Monocyte migration in the absence of stimulus was routinely <12 cells/field. In previous kinetic studies, monocytes were shown not to detach from the distal filter surface until after 2-h incubation. The 90-min incubation used in this study thus minimizes the possibility that differences in cell adherence affected migration.
Statistics. All data are presented as the mean (±SEM) number of monocytes that migrated. The mean chemotactic responses among the groups were tested for normality by the Wilk-Shapiro test, and the level of significance was determined using the equal variance and unequal variance t tests.
Results
Study population. The clinical and laboratory features of the AIDS patients and the control subjects are presented in Table  I Fig. 1 , peripheral blood monocyte chemotaxis was markedly reduced in the AIDS patients with KS and/or OI compared with that of the heterosexual control subjects. This reduction was observed for all three chemoattractants: FMLP (P > 0.001), and the inflammatory stimuli, LDCF (P > 0.0001), and C5a (P > 0.0001). The patients' mean monocyte migration responses to LDCF and C5a were <20% of the responses of monocytes from the normal subjects. Interestingly, monocyte migration to these stimuli was tested in an eighth patient who was thought initially to have AIDS because of the apparent presence of M. avium intracellulare in a lymph node and the history of intravenous drug abuse. Chemotactic activity was normal or near normal for all stimuli, and the individual was subsequently determined not to have AIDS based upon a normal lymphocyte profile and the presence of atypical mycobacterium in the lymph node. This patient's normal monocyte activity emphasizes the relationship between defective monocyte chemotactic function and the presence of the disease. This patient was subsequently excluded from the study.
The chemotactic activity of monocytes from the homosexuals with lymphadenopathy and an abnormal immunological profile was reduced, although not significantly, in response to FMLP, LDCF, and C5a compared with that of the healthy heterosexuals (Fig. 1) . There was thus a trend toward depressed monocyte chemotaxis in this subset of homosexual patients, but the depression was not as marked as for that of the homosexuals with AIDS. In contrast to the responses by monocytes from homosexuals with AIDS, the monocytes from each of seven healthy homosexuals without AIDS exhibited normal chemotaciic responses to FMLP, LDCF, and C5a compared with the responses by monocytes from the healthy heterosexual subjects (Fig. 1) (Fig. 3) .
Monocyte migration in non-AIDS patients. Monocytes from additional control groups that consisted of three patients with bacterial sepsis, four with lymphoma, three with tuberculosis, one with sarcoidosis, and one with Wegener's granulomatosis were also investigated for their chemotactic responses. As shown in Fig. 4 , monocyte chemotaxis was not reduced in these groups compared with that of matched control subjects.
Thus, sepsis, cancer, anergy-associated conditions, and antibiotic therapy and/or chemotherapy in these patients did not depress the chemotactic function of their monocytes.
Effect ofAIDS serum on monocyte migration. To determine whether a serum factor was responsible for the inhibition of monocyte migratory function in the AIDS patients, monocytes from ai healthy control subject were preincubated with different concentrations of serum from three AIDS patients, three healthy homosexuals, and three healthy heterosexuals, and then tested for chemotactic function. As shown in Fig. 5 
wards soluble products of G. lamblia. As shown in Table II , monocytes from seven patients with AIDS exhibited significantly reduced migration to the optimal concentration of soluble G. lamblia in comparison to migration by monocytes from the control subjects and the healthy homosexuals (P < 0.025). Thus, in addition to an inability of monocytes from AIDS patients to respond normally to FMLP and inflammatory chemotactic stimuli (CSa, LDCF), monocytes from these individuals also do not respond normally to chemotactic products of a protozoan parasite.
Discussion
We investigated the chemotactic capability of peripheral blood monocytes from patients with AIDS. In contrast to the chemotactic responses of monocytes from healthy heterosexuals, monocytes from homosexuals with AIDS exhibited reduced directed migration to three distinct chemoattractants, FMLP, LDCF, and O~a. Monocyte chemotaxis in homosexuals with lymphadenopathy and an abnormal immunologic profile was intermediate between that ofthe AIDS patients and the healthy heterosexual control subjects. Monocyte chemotaxis in healthy homosexuals without evidence of lymphadenopathy or AIDS was not reduced. The inability of monocytes from AIDS patients with KS and/or OI to respond to any of the three stimuli studied suggests that the defect is not limited to a single receptorstimulus interaction, but is likely the consequence of a more generalized defect. In addition, since the suppressed chemotactic response occurred at all concentrations of each stimulus, the reduced migration is not the consequence of a shift in monocyte sensitivity to the stimuli. Also, the observations indicate that the reduced monocyte migration is due to a defect in monocyte chemotactic function and not a serum factor that inhibits chemotaxis. Furthermore, random migration of patients' monocytes exhibited no significant decrease or increase in activity in the absence of defined chemoattractants compared with that of the control subjects (Figs. 1-3 , Table II ). Monocytes from patients with sepsis, lymphoma, and anergy-associated conditions did not exhibit defective chemotactic function, even in the setting of in vivo antibiotic therapy and chemotherapy. Also, monocytes from the three AIDS patients with KS and/or 01 who were not receiving antibiotics exhibited defective migratory responses comparable to those of the four AIDS patients receiving antibiotics. These observations suggest that the defective chemotactic function that we have observed in AIDS patients with KS and/or OI is not solely the consequence of bacterial infections, neoplasms, anergy, chemotherapy, or drug therapy.
In addition to impaired chemotaxis to FMLP, C5a and LDCF, monocytes from the AIDS patients were defective in their migration response to G. lamblia. Patients' monocytes thus exhibited impaired chemotaxis to the inflammatory stimuli (LDCF and COa), the bacterial analogue FMLP, as well as products of a protozoan parasite. This defect in migratory capability could contribute to the reduced immune-mediated inflammatory reaction to some organisms that has been observed in patients with AIDS. For example, M. avium intracellulare, which occurs frequently in AIDS patients, elicits minimal or no granulomatous reaction (32) . A potential mechanism for this impaired granuloma formation is that as these ubiquitous bacteria invade the host, monocytes are not appropriately recruited in sufficient numbers to elicit a macrophage-mediated granulomatous reaction. In (36) to be present in human malignant cell lines and blast-transformed cells. These observations may be of particular relevance to the depressed migratory response that we have observed in AIDS patients since cytopathic human T-lymphotropic retroviruses (HTLV-III) have been detected and isolated from patients with AIDS and pre-AIDS (37) (38) (39) (40) (41, 42) .
In a preliminary report (43), decreased random locomotion by monocytes was observed in 10% of symptom-free homosexual men. In contrast, we studied directed migration to four specific chemoattractants over a wide dose-response range and observed that monocyte chemotaxis was normal in healthy homosexuals without lymphadenopathy or AIDS. However, homosexuals with lymphadenopathy and an abnormal immunological profile demonstrated a decrease, although not significant, in monocyte chemotactic function. Furthermore, although chemotaxis was clearly reduced in AIDS patients with only Kaposi's sarcoma, the defect was most apparent in those AIDS patients with clinically defined opportunistic infections. These observations suggest that the defect in monocyte function is not secondary to the clinically apparent opportunistic infections, although opportunistic infections may potentiate the defect. Regardless of whether suppressed monocyte chemotaxis is a primary or secondary event in patients with AIDS, the inability of peripheral blood monocytes to migrate to inflammatory stimuli and to chemotactic products of infectious organisms could contribute to the inadequate host response to certain opportunistic organisms and neoplasms characteristic of this disease.
